Use of monoclonal antibodies in cancer immunotherapy: types and mechanisms of action
Immunotherapy is one of the most innovative treatments in the current field of oncology and consists of stimulating the immune system to eliminate tumoral cells. Monoclonal antibodies (mAbs) are glycoproteins secreted by B-cells capable of recognizing and neutralizing foreign organisms or antigens....
Main Authors: | Paola Damián-Blanco, Selene Ahuexoteco-Sánchez, Adrián A. Carbajal-Gallardo, Fredi C. Coctecon-Chávelas, Cynthia Rodríguez-Nava, Amalia Vences-Velázquez, Yolanda Medina-Flores, Olga Mata-Ruíz, Lourdes Lloret-Sánchez, Karen Cortés-Sarabia |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2023-07-01
|
Series: | Boletín Médico del Hospital Infantil de México |
Subjects: | |
Online Access: | https://www.bmhim.com/frame_esp.php?id=367 |
Similar Items
-
Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
by: Cynthia Rodríguez-Nava, et al.
Published: (2023-06-01) -
Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995) -
Immunotherapy with Antibodies in Multiple Myeloma: Monoclonals, Bispecifics, and Immunoconjugates
by: Christie P. M. Verkleij, et al.
Published: (2021-03-01) -
Monoclonal antibodies /
by: Peter, J. H., et al.
Published: (1992) -
Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al.